Table VI.
Illustration of SMARTER MAUT analysis
| Major criterion |
Effectiveness | Adverse Effects | Cost | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Priority | 0.55 | 0.3 | 0.16 | ||||||||
| Symptom relief |
Halt disease progression |
Serious | Common | ||||||||
|
Priority rank |
4 | 1 | 2 | 5 | 3 | ||||||
| Priority | 0.09 | 0.46 | 0.26 | 0.04 | 0.16 | ||||||
|
Original data |
Utility Score |
Original data |
Utility score |
Original data |
Utility score |
Original data |
Utility score |
Original data |
Utility score |
Normalized Total score a |
|
| Drug A | 95% | 92 | 65% | 42 | 0.1% | 95 | 1% | 95 | $ 15 | 90 | 0.35 |
| Drug B1 | 85% | 83 | 75% | 58 | 0.5% | 75 | 5% | 75 | $ 50 | 67 | 0.34 |
| Drug C | 85% | 75 | 85% | 75 | 1.0% | 50 | 10% | 50 | $ 100 | 33 | 0.31 |
a
Total score calculated by multiplying each option's rank order centroid times the utility score for each criterion, summing over all criteria, and then normalizing the results. For example, Drug A score (before normalization) = (0.09 × 92) +( 0.46 × 42) + (0.26 × 95) + (0.04 × 95) + (0.16 × 90)